<DOC>
	<DOCNO>NCT01448213</DOCNO>
	<brief_summary>The purpose study compare two different commonly use steroid dose regimen Descemet 's membrane endothelial keratoplasty ( DMEK ) transplant surgery . The investigator hope determine one effective prevent rejection equally effective .</brief_summary>
	<brief_title>Comparison Two Steroid Regimens Prevent Transplant Rejection After Corneal Transplant ( DMEK )</brief_title>
	<detailed_description>Graft rejection one leading cause cornea transplant failure . To help prevent rejection , corticosteroid eye drop use transplant surgery . The steroid eye drop dose regimen varies surgeon surgeon , study do determine optimum dose regimen .</detailed_description>
	<mesh_term>Fuchs ' Endothelial Dystrophy</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Fluorometholone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>INCLUSION CRITERIA : The following requirement inclusion study : Male female patient , least 18 year age , candidate DMEK due corneal endothelial dysfunction undergone DMEK within last 7 week Patient able willing administer eye drop . Patient able comprehend sign Informed Consent form . Patient likely complete entire oneyear course study . Patient best correct visual acuity ( BCVA ) least 20/200 fellow eye . Corneal neovascularization judge exclusion criterion study EXCLUSION CRITERIA : The follow exclusion criterion patient study : A patient previous fail graft study eye history prior rejection episode A patient exhibit intraocular inflammation A patient know sensitivity ingredient study medication A patient condition ( i.e. , UNCONTROLLED systemic disease ) situation investigator 's opinion may put patient significant risk , may confound study result , may interfere significantly patient 's participation study A patient abnormal eyelid function A patient exhibit active corneal ulceration , keratitis , conjunctivitis , history herpetic keratitis A patient presence ocular disease would interfere evaluation study treatment A patient history noncompliance use prescribed medication A patient concurrently involve participate another clinical trial within 30 day prior enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>DMEK</keyword>
	<keyword>Rejection</keyword>
	<keyword>Corticosteroid</keyword>
</DOC>